Sanofi India Limited held its 69th Annual General Meeting (AGM) on 15 May 2025 via Video Conferencing / Other Audio Visual Means, attended by 76 shareholders. The meeting discussed and approved several key resolutions, including:
- Adoption of the Annual Audited Financial Statements (Standalone and Consolidated) for the Financial Year ended 31 December 2024.
- Declaration of a final dividend of ₹ 117 per equity share of ₹ 10 each for the Financial Year ended 31 December 2024.
- Re-appointment of Directors Ms. Renee Amonkar and Mr. Rachid Ayari, who retired by rotation.
- Re-appointment of Mr. Rahul Bhatnagar as Independent Director for a second term from 29 July 2025 to 28 July 2030.
- Re-designation of Mr. Rodolfo Hrosz as Non-Executive Director.
- Appointment of M/s. Parikh & Associates as Secretarial Auditor for a term of five consecutive years from FY 2025 to FY 2029.
- Ratification of remuneration payable to the Cost Auditors for the Financial Year ending 31 December 2025.
The Chairman presented key developments and highlighted the operational and financial performance for the year 2024. The Chairman and the Whole-time Director & CFO responded to shareholder queries. The voting results will be disseminated in due course.